Duda S H, Laniado M, Kopp A F, Grönewäller E, Aicher K P, Pavone P, Jehle E, Claussen C D
Abteilung für Radiologische Diagnostik, Eberhard-Karls-Universität, Tübingen.
Rofo. 1994 Jan;160(1):46-51. doi: 10.1055/s-2008-1032371.
Superparamagnetic iron oxide particles (AMI-25) were evaluated as a liver contrast agent in high-field MR imaging (1.5 T). 16 patients with up to 5 presumed focal liver lesions (liver metastases n = 8, HCC n = 5, Klatskin tumours n = 2, FNH n = 1) received 15 mumol Fe/kg BW intravenously and were examined via standard T1- and T2-weighted spin-echo sequences. Quantitative image analysis showed a post-contrast increase of the contrast-to-noise ratio (C/N) from 1.6 to 7.4 on SE 2,500/15 images (p < .05). However, C/N was in the same range on plain SE 2,500/90 scans. Blind evaluation by two independent readers revealed that AMI-25-enhanced images did not provide a significantly increased number of lesions. Two patients reported minor, self-limited side-effects (flush, back pain). We conclude that in contrast to reports at mid-field MR imagers, the use of AMI-25 at 1.5 T does not significantly improve the detection of focal liver lesions on conventional SE images.
超顺磁性氧化铁颗粒(AMI-25)作为肝脏对比剂在高场强磁共振成像(1.5T)中进行了评估。16例患者有多达5个疑似肝脏局灶性病变(肝转移瘤8例,肝细胞癌5例,肝门部胆管癌2例,局灶性结节性增生1例),静脉注射15μmol Fe/kg体重,并通过标准T1加权和T2加权自旋回波序列进行检查。定量图像分析显示,在SE 2500/15图像上,对比剂增强后对比噪声比(C/N)从1.6增加到7.4(p<0.05)。然而,在普通SE 2500/90扫描中,C/N处于相同范围。两位独立阅片者的盲法评估显示,AMI-25增强图像上显示的病变数量没有显著增加。两名患者报告有轻微的、自限性的副作用(脸红、背痛)。我们得出结论,与中场磁共振成像仪的报告不同,在1.5T场强下使用AMI-25并不能显著提高常规SE图像上肝脏局灶性病变的检出率。